Exercise-Based Rehabilitation in Severe COVID-19 Survivors with Long COVID: A Randomized Controlled Pilot Study.

Publication date: Apr 29, 2026

Post-hospital rehabilitation is essential for survivors of severe COVID-19, as prolonged immobility and clinical severity often lead to muscle weakness, reduced cardiovascular capacity, and impaired respiratory function. Physical exercise during and after hospitalization may mitigate these effects and support functional recovery. This study aimed to evaluate the effectiveness of a physical exercise-based rehabilitation program in survivors of severe COVID-19. A randomized clinical trial was conducted with 30 survivors allocated to two groups: multicomponent exercise (GEm) and multicomponent exercise combined with inspiratory muscle training (GEmTMI). The interventions were performed three times per week for 40-60 min. Quality of life, physical activity level, functional status, and physical capacity were assessed before and after six weeks. Comparisons between GEm and GEmTMI showed significant differences in the 6 min walk test (6MWT) at baseline (p = 0. 043) and in the Physical Activity Index (IPAQ) after the intervention (p = 0. 002). When the total sample was analyzed, significant improvements were observed across all outcomes after rehabilitation, including quality of life (SF-36), functional capacity (PCFS), physical activity level (IPAQ), respiratory muscle strength, and additional functional tests. Notable improvements included SF-36 Physical Functioning (p = 0. 006) and Social Functioning (p = 0. 009), PCFS (p = 0. 011), IPAQ (p = 0. 012), and performance in the 6MWT, STS, STS-1min, TUG, handgrip strength, PEmax, and PImax (all p

Open Access PDF

Concepts Keywords
Cardiovascular Aged
Handgrip COVID-19
Hospitalization exercise
Pilot Exercise Therapy
Female
Humans
Male
Middle Aged
Muscle Strength
Pandemics
Pilot Projects
Post-Acute COVID-19 Syndrome
post-COVID-19 syndrome
Quality of Life
quality of life
SARS-CoV-2
Survivors
telerehabilitation

Semantics

Type Source Name
disease MESH COVID-19
disease MESH Long COVID
disease MESH muscle weakness
disease MESH included
drug DRUGBANK Sodium Tetradecyl Sulfate
drug DRUGBANK Isoxaflutole
drug DRUGBANK Ribostamycin
drug DRUGBANK Coenzyme M
disease MESH syndrome
disease MESH viral diseases
disease MESH Middle East respiratory syndrome
disease MESH severe acute respiratory syndrome
disease MESH fatigue
disease MESH joint pain
disease MESH chest pain
disease MESH headaches
disease MESH myalgia
disease MESH brain fog
disease MESH anxiety
disease MESH inflammation
disease MESH sarcopenia
disease MESH frailty
disease MESH obesity
disease MESH muscle atrophy
disease MESH atrophy
disease MESH clinical progression
drug DRUGBANK Oxygen
disease MESH reinfection
disease MESH atrial fibrillation
disease MESH heart failure
disease MESH paraplegia
disease MESH quadriplegia
disease MESH deformities
drug DRUGBANK Trestolone
disease MESH dementia
disease MESH Plan
disease MESH car
disease MESH metabolic diseases
disease MESH body weight
disease MESH dyspnea
disease MESH pain
disease MESH infection
disease MESH death
drug DRUGBANK Water
drug DRUGBANK BIA
disease MESH chronic diseases
disease MESH tachycardia
drug DRUGBANK Cysteamine
drug DRUGBANK Methionine
disease MESH face
drug DRUGBANK 8-cyclopentyl-1 3-dipropylxanthine
disease MESH CPX
disease MESH ischemia
disease MESH ataxia
disease MESH dizziness
disease MESH pallor
disease MESH cyanosis
disease MESH presyncope
disease MESH supraventricular tachycardia
disease MESH IBM
disease MESH Hypertension
disease MESH Asthma
pathway KEGG Asthma
disease MESH Arthritis
drug DRUGBANK Hyaluronic acid
disease MESH non communicable diseases
disease MESH cardiovascular disease
disease MESH stroke
disease MESH overweight
disease MESH respiratory failure
pathway KEGG Oxidative phosphorylation
disease MESH critical illness
disease MESH long term infection
drug DRUGBANK Efavirenz
disease MESH Dis
drug DRUGBANK Isosorbide Mononitrate
disease MESH ICD
disease MESH Respiratory Diseases
disease MESH sick sinus syndrome
disease MESH cognitive impairment
disease MESH Bie
drug DRUGBANK Mirtazapine
drug DRUGBANK Sulfasalazine
disease MESH aos
disease MESH Ito
disease MESH sepsis
disease MESH mitochondrial disorder
disease MESH Park
disease MESH bed
disease MESH Myopathies
disease MESH cachexia
disease MESH Injury
disease MESH Musculoskeletal Pain
disease MESH Pneumonia
disease MESH Critical illness polyneuropathy
disease MESH acute respiratory distress syndrome
disease MESH postintensive care syndrome
disease MESH Rheumatoid Arthritis
pathway KEGG Rheumatoid arthritis

Original Article

(Visited 2 times, 1 visits today)

Leave a Comment

Your email address will not be published. Required fields are marked *